Suchandrima Bhowmik

Suchandrima Bhowmik

Feature Writer

M.Sc. Microbiology

Suchandrima has a Bachelor of Science (B.Sc.) degree in Microbiology and a Master of Science (M.Sc.) degree in Microbiology from the University of Calcutta, India. The study of health and diseases was always very important to her. In addition to Microbiology, she also gained extensive knowledge in Biochemistry, Immunology, Medical Microbiology, Metabolism, and Biotechnology as part of her master's degree.

See more

Suchandrima is also an avid writer and has written for some reputable Indian organizations. However, she decided to pursue scientific writing as it would be the best combination of what she loves, research and writing. Additionally, she authored a book chapter that was published in Elsevier.

Currently she is also working as a medical writer where she has to develop articles for several diseases and also provide detailed descriptions of medicines and other associated products.

She is very enthusiastic about working at AzoNetwork's medical website, News Medical, since it will keep her updated about the latest breakthroughs in medical and health science that are happening around the world.

Apart from science, her hobbies include reading and painting. She has an art page on Instagram with over 1k followers and plans not to lose touch with her hobbies. She loves reading novels, the last novel she read was Men without Women by Haruki Murakami.

See less

Articles from Suchandrima

Study reveals factors responsible for increased risk of aerosol transmission for SARS-CoV-2 Delta and Omicron

Study reveals factors responsible for increased risk of aerosol transmission for SARS-CoV-2 Delta and Omicron

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Immunological factors associated with impaired BNT162b2 mRNA vaccine response in older adults

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Characteristics and outcomes in patients hospitalized with COVID-19 in South Africa

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

Omicron will outcompete Delta variant for next 4-5 months globally: Genome study

Omicron will outcompete Delta variant for next 4-5 months globally: Genome study

An evaluation of the association between COVID vaccination and myocarditis in 42 million people aged 13 or older

An evaluation of the association between COVID vaccination and myocarditis in 42 million people aged 13 or older

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

New report on 1.23 million breakthrough symptomatic SARS-CoV-2 infections by vaccine

How the SARS-CoV-2 Delta variant grew to dominate the UK epidemic

How the SARS-CoV-2 Delta variant grew to dominate the UK epidemic

How COVID vaccines protected Americans against the Delta variant

How COVID vaccines protected Americans against the Delta variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.